BIAF
bioAffinity Technologies, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$9.43
+7.77%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 1.37x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.50x
- Price / sales
- 0.96x
- Price / cash flow
- -0.49x
Enterprise value
- Enterprise value
- $4.7M
- EV / sales
- 0.79x
- EV / EBITDA
- -0.32x
- EV / EBIT
- -0.38x
- Market cap
- $5.7M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026